Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-13-009278
Filing Date
2013-05-28
Accepted
2013-05-28 19:31:16
Documents
1
Period of Report
2013-05-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3799
  Complete submission text file 0001179110-13-009278.txt   5126
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Issuer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BRISTOL MYERS SQUIBB CO 345 PARK AVE NEW YORK NY 10164
Business Address
RINGROSE PETER S (Reporting) CIK: 0001199298 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29889 | Film No.: 13876476